BENJAMIN GUDORF: Open Payments
NPI 1740704857 · ROCKFORD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 21 payments from 11 companies in 2025. Trend: 2023 $1,275 · 2024 $1,480 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 3 | $102 |
| Abbott Laboratories | 4 | $96 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Novo Nordisk Inc | 2 | $42 |
| Tandem Diabetes Care, Inc. | 2 | $36 |
| Ascensia Diabetes Care Us Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Medtronic, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Omnipod, FREESTYLE LIBRE 3, Ozempic, t:slim X2 Insulin Pump with Control-IQ, BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across OH — which companies pay providers there.
